Clinical trials
Recruiting Carcinoma, Hepatocellular trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 5 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Canadian Cancer Trials Group | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Fore Biotherapeutics | 1 |
| Guerbet | 1 |
| Hamilton Health Sciences Corporation | 1 |
| Maastricht University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 19 |
| Cholangiocarcinoma | 3 |
| Liver Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Disease | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.